CERS:NASDAQ
Cerus Corp
2,30 US$
arrow_upward
+0,88%(+0,020) 1D
9 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
2,31 US$
High
2,33 US$
Low
2,27 US$
Mkt. cap
463,51 მლნ.
Avg. vol.
1,65 მლნ.
Volume
14,00
52-wk high
3,47 US$
52-wk low
1,38 US$
EPS
-0,03 US$
Beta
1,83
Shares outstanding
201,52 მლნ.
No. of employees
268
Open
2,31 US$
High
2,33 US$
Low
2,27 US$
Mkt. cap
463,51 მლნ.
Avg. vol.
1,65 მლნ.
Volume
14,00
52-wk high
3,47 US$
52-wk low
1,38 US$
EPS
-0,03 US$
Beta
1,83
Shares outstanding
201,52 მლნ.
No. of employees
268
News stories
From web sources and news partners
marketscreener.com
·
8 წუთის წინ
Goldman Sachs Adjusts Price Target on Dow to $31 From $33
Yahoo Finance
·
1 საათის წინ
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Sahi
·
59 წუთის წინ
Black Box Shows Interest In Nasdaq Listed Aeries Technology Reporting $70 Million FY26 Revenue
Bloomberg.com
·
1 საათის წინ
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
Foundedსექ 1991
HeadquartersConcord, კალიფორნია, ამერიკის შეერთებული შტატები
SectorMedical device
Websitecerus.com